Welcome to our dedicated page for Altria Group SEC filings (Ticker: MO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Altria Group, Inc. (MO) SEC filings page brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the information. As a Virginia corporation with common stock listed on the New York Stock Exchange, Altria files periodic and current reports that cover its financial condition, capital structure, governance and material events.
Through this page, readers can access Form 8-K current reports in which Altria discloses items such as quarterly and nine-month financial results, expansions of its share repurchase program, leadership and Board changes, new debt issuances and amendments to its revolving credit agreement. These filings often incorporate press releases that detail net revenues, adjusted diluted EPS, special items, dividend actions and share repurchase activity.
Altria’s filings also describe its registered securities, including common stock and senior unsecured notes with various maturities, and provide information on guarantees by Philip Morris USA Inc. for certain notes. Other exhibits referenced in 8-K filings include underwriting agreements, indentures, guarantee agreements and legal opinions related to securities offerings.
On Stock Titan, AI-generated summaries highlight the key points in lengthy filings, helping users quickly identify what changed in a given report, such as updates to guidance, capital allocation decisions or material agreements. Real-time ingestion from EDGAR means new MO filings appear promptly, while structured views of items like debt offerings, credit facility amendments and Board or executive transitions make it easier to follow Altria’s corporate and financing activities.
Investors and researchers can use this page to review Altria’s historical and recent SEC disclosures, understand how the company reports its performance and capital structure, and see how management communicates material events to the market.
Altria Group (MO) Q2-25 10-Q highlights
For the six months ended 6/30/25, net revenues fell 3.6% YoY to $11.36 bn while net earnings declined 41.8% to $3.46 bn (EPS $2.04 vs $3.41). The prior-year period included a $2.7 bn gain from the sale of IQOS U.S. rights. Ex-gain, operating trends were steadier: gross profit up 2.1% to $7.10 bn; operating income down 3.6% to $5.02 bn after a $873 m non-cash goodwill impairment tied to the e-vapor unit.
Segment OCI: Smokeable products rose 2.9% to $5.40 bn; oral tobacco surged 75% to $0.93 bn, offset by a $1.12 bn loss in “All Other” (e-vapor, Horizon, etc.).
Cash & leverage: Operating cash flow increased to $2.93 bn (vs $2.80 bn), but cash & equivalents dropped to $1.29 bn from $3.13 bn at 12/31/24 following $600 m of share buybacks and $1.61 bn debt repayment. Long-term debt stands at $23.65 bn; book equity remains negative at $(3.21) bn.
Capital returns: A new $1 bn repurchase program was authorized in Jan-25; $0.6 bn completed, $0.4 bn remains. Dividends declared YTD totaled $3.45 bn ($2.04 / share).
Key events: • ITC exclusion order removed NJOY ACE from U.S. market, triggering the goodwill write-down. • No new share restrictions on subsidiaries’ dividend capacity. • Contingent consideration for NJOY flavor PMT approvals increased by $25 m to $45 m.
Liquidity appears sufficient with $2.6 bn unused under an October-2028 revolving credit facility, but ongoing litigation and regulatory actions remain contingencies.